Novartis discloses seven new tumor cases in children receiving gene therapy Zolgensma
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Novartis reported seven previously undisclosed tumor cases in children treated with Zolgensma for spinal muscular atrophy, raising the total number of tumor reports to nine since the gene therapy received approval in 2019.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu